Spruce Biosciences Inc (NASDAQ: SPRB) started the day on Thursday, with a price decrease of -9.87% at $0.39, before settling in for the price of $0.43 at the close. Taking a more long-term approach, SPRB posted a 52-week range of $0.38-$5.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -22.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 23.23%. This publicly-traded company’s shares outstanding now amounts to $41.30 million, simultaneously with a float of $27.36 million. The organization now has a market capitalization sitting at $15.99 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5108, while the 200-day Moving Average is $0.8126.
Spruce Biosciences Inc (SPRB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Spruce Biosciences Inc’s current insider ownership accounts for 33.75%, in contrast to 22.15% institutional ownership. According to the most recent insider trade that took place on Mar 21 ’24, this organization’s 10% Owner sold 465,021 shares at the rate of 0.75, making the entire transaction reach 350,951 in total value, affecting insider ownership by 2,550,000. Preceding that transaction, on Mar 18 ’24, Company’s 10% Owner sold 842,020 for 0.77, making the whole transaction’s value amount to 647,008. This particular insider is now the holder of 3,968,000 in total.
Spruce Biosciences Inc (SPRB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
Spruce Biosciences Inc’s EPS increase for this current 12-month fiscal period is 23.23% and is forecasted to reach -0.55 in the upcoming year.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
Let’s observe the current performance indicators for Spruce Biosciences Inc (SPRB). It’s Quick Ratio in the last reported quarter now stands at 5.36. The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.25.
In the same vein, SPRB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.96, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.55 at the market close of one year from today.
Technical Analysis of Spruce Biosciences Inc (SPRB)
If we take a close look at the recent performances of Spruce Biosciences Inc (NASDAQ: SPRB), its last 5-days Average volume was 2.38 million that shows progress from its year to date volume of 0.7 million. During the previous 9 days, stock’s Stochastic %D was recorded 26.90% While, its Average True Range was 0.0517.
Raw Stochastic average of Spruce Biosciences Inc (SPRB) in the period of the previous 100 days is set at 1.21%, which indicates a major fall in contrast to 1.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.45% that was higher than 63.38% volatility it exhibited in the past 100-days period.
